Particle radiotherapy and molecular therapies: mechanisms and strategies towards clinical applications
暂无分享,去创建一个
[1] R. Kanaar,et al. DNA Double Strand Break Repair Pathways in Response to Different Types of Ionizing Radiation , 2021, Frontiers in Genetics.
[2] M. Durante,et al. Physics and biomedical challenges of cancer therapy with accelerated heavy ions , 2021, Nature Reviews Physics.
[3] John O. Prior,et al. Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy , 2021, Cancer discovery.
[4] J. Welsh,et al. Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer , 2021, Frontiers in Oncology.
[5] C. Lord,et al. Targeting the DNA damage response in immuno-oncology: developments and opportunities , 2021, Nature Reviews Cancer.
[6] S. Ganesan,et al. Understanding and overcoming resistance to PARP inhibitors in cancer therapy , 2021, Nature Reviews Clinical Oncology.
[7] P. Zhou,et al. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy , 2021, Signal Transduction and Targeted Therapy.
[8] K. O'Byrne,et al. Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review , 2021, Frontiers in Molecular Biosciences.
[9] J. Parsons,et al. USP9X Is Required to Maintain Cell Survival in Response to High-LET Radiation , 2021, Frontiers in Oncology.
[10] R. Timmerman,et al. Future Directions in the Use of SAbR for the Treatment of Oligometastatic Cancers. , 2021, Seminars in radiation oncology.
[11] Maxim N. Artyomov,et al. Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads , 2021, Proceedings of the National Academy of Sciences.
[12] L. Zhong,et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives , 2021, Signal Transduction and Targeted Therapy.
[13] R. Johnstone,et al. Regulatory T cells shape the differential impact of radiation dose-fractionation schedules on host innate and adaptive anti-tumor immune defenses: Immunosuppressive implications of radiotherapy. , 2021, International journal of radiation oncology, biology, physics.
[14] Tiara Bunga Mayang Permata,et al. Modulation of immune responses by DNA damage signaling. , 2021, DNA repair.
[15] S. Jackson,et al. Interfaces between cellular responses to DNA damage and cancer immunotherapy , 2021, Genes & development.
[16] L. Bouwens,et al. Fractionated radiation severely reduces the number of CD8+ T cells and mature antigen presenting cells within lung tumors. , 2021, International journal of radiation oncology, biology, physics.
[17] A. Murphy,et al. Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses , 2021, Science Immunology.
[18] Laurentiu M. Pop,et al. Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy (PULSAR) in preclinical models enhances single agent immune checkpoint blockade. , 2021, International journal of radiation oncology, biology, physics.
[19] J. Pinto,et al. Biological bases of cancer immunotherapy , 2021, Expert Reviews in Molecular Medicine.
[20] F. Brandalise,et al. A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma , 2021, Frontiers in Neuroscience.
[21] M. Durante,et al. Modeling Radioimmune Response—Current Status and Perspectives , 2021, Frontiers in Oncology.
[22] H. Park,et al. Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells , 2021, Cells.
[23] R. Weichselbaum,et al. Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity , 2021, Science Translational Medicine.
[24] J. Sarkaria,et al. Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining , 2021, Cancer Research.
[25] L. Galluzzi,et al. Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer , 2021, Clinical Cancer Research.
[26] A. Chinnaiyan,et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination , 2021, Nature Medicine.
[27] H. Pyo,et al. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] Yi-long Wu,et al. Brief report: Four-year survival with durvalumab after chemoradiotherapy in Stage III NSCLC - an update from the PACIFIC trial. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[29] J. Parsons,et al. The E3 Ubiquitin Ligase NEDD4L Targets OGG1 for Ubiquitylation and Modulates the Cellular DNA Damage Response , 2020, Frontiers in Cell and Developmental Biology.
[30] Haidong Dong,et al. Radiation and immunotherapy: emerging mechanisms of synergy , 2020, Journal of thoracic disease.
[31] Joe Y. Chang,et al. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. , 2020, The Lancet. Respiratory medicine.
[32] J. Welsh,et al. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma , 2020, Journal for ImmunoTherapy of Cancer.
[33] M. Durante,et al. Carbon Ion Radiobiology , 2020, Cancers.
[34] M. Durante,et al. Reduction of lung metastases in a mouse osteosarcoma model treated with carbon ions and immune checkpoint inhibitors. , 2020, International journal of radiation oncology, biology, physics.
[35] W. V. van Cappellen,et al. Comparison of High- and Low-LET Radiation-Induced DNA Double-Strand Break Processing in Living Cells , 2020, International journal of molecular sciences.
[36] N. Agarwal,et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. , 2020, European urology.
[37] R. Mohan,et al. Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons. , 2020, Neuro-oncology.
[38] J. Parsons,et al. Base excision repair and its implications to cancer therapy , 2020, Essays in biochemistry.
[39] Caicun Zhou,et al. cGAS-STING, an important pathway in cancer immunotherapy , 2020, Journal of Hematology & Oncology.
[40] J. Welsh,et al. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[41] M. Weller,et al. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma , 2020, JAMA oncology.
[42] V. Hornung,et al. Molecular mechanisms and cellular functions of cGAS–STING signalling , 2020, Nature Reviews Molecular Cell Biology.
[43] L. Galluzzi,et al. Immunomodulation by anticancer cell cycle inhibitors , 2020, Nature Reviews Immunology.
[44] P. Lambin,et al. Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy. , 2020, Seminars in radiation oncology.
[45] F. Marincola,et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death , 2020, Journal for ImmunoTherapy of Cancer.
[46] M. Pruschy,et al. The relative biological effectiveness of proton irradiation in dependence of DNA damage repair. , 2020, The British journal of radiology.
[47] G. Iliakis,et al. Chromosome breaks generated by low doses of ionizing radiation in G2-phase are processed exclusively by gene conversion. , 2020, DNA repair.
[48] Bjorn Baselet,et al. Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance , 2020, Frontiers in Oncology.
[49] M. Durante,et al. Differential Repair Protein Recruitment at Sites of Clustered and Isolated DNA Double-Strand Breaks Produced by High-Energy Heavy Ions , 2020, Scientific Reports.
[50] M. Cornforth. Occam’s broom and the dirty DSB: cytogenetic perspectives on cellular response to changes in track structure and ionization density , 2020, International journal of radiation biology.
[51] A. Balmain,et al. Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice , 2020, Nature Communications.
[52] A. Shibata,et al. Canonical DNA non-homologous end-joining; capacity versus fidelity , 2020, The British journal of radiology.
[53] N. Sharma,et al. Clustered DNA Double-Strand Breaks: Biological Effects and Relevance to Cancer Radiotherapy , 2020, Genes.
[54] J. Metz,et al. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer. , 2019, JAMA oncology.
[55] G. Iliakis,et al. Necessities in the Processing of DNA Double Strand Breaks and Their Effects on Genomic Instability and Cancer , 2019, Cancers.
[56] Jingfang Zhao,et al. Comparison of the effects of photon, proton and carbon-ion radiation on the ecto-calreticulin exposure in various tumor cell lines. , 2019, Annals of translational medicine.
[57] D. Aoki,et al. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma , 2019, Journal of gynecologic oncology.
[58] J. Aten,et al. Ultra-soft X-ray system for imaging the early cellular responses to X-ray induced DNA damage , 2019, Nucleic acids research.
[59] O. Elemento,et al. Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system , 2019, Genome Medicine.
[60] Nicole M. Chapman,et al. Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression. , 2019, Cancer research.
[61] R. Sánchez-Prieto,et al. P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy. , 2019, Cancer letters.
[62] Clemens Grassberger,et al. Assessing the interactions between radiotherapy and antitumour immunity , 2019, Nature Reviews Clinical Oncology.
[63] C. Trautmann,et al. Applied nuclear physics at the new high-energy particle accelerator facilities , 2019, Physics Reports.
[64] A. Shibata,et al. Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy , 2019, Front. Oncol..
[65] M. Koizumi,et al. Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma , 2019, Oncotarget.
[66] M. Kneilling,et al. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy. , 2018, JCI insight.
[67] M. Hausmann,et al. Recruitment of 53BP1 Proteins for DNA Repair and Persistence of Repair Clusters Differ for Cell Types as Detected by Single Molecule Localization Microscopy , 2018, International journal of molecular sciences.
[68] Joe Y. Chang,et al. Time to abandon single-site irradiation for inducing abscopal effects , 2018, Nature Reviews Clinical Oncology.
[69] Yuzhen Niu,et al. Genistein sensitizes glioblastoma cells to carbon ions via inhibiting DNA-PKcs phosphorylation and subsequently repressing NHEJ and delaying HR repair pathways. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[70] R. Emerson,et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade , 2018, Nature Medicine.
[71] Yoshiyuki Suzuki,et al. High linear energy transfer carbon-ion irradiation increases the release of the immune mediator high mobility group box 1 from human cancer cells , 2018, Journal of radiation research.
[72] C. Drake,et al. Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy , 2018, Clinical Cancer Research.
[73] M. Durante,et al. Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway , 2018, Front. Oncol..
[74] Arnaud Boyer,et al. Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer. , 2018, Journal of thoracic disease.
[75] Alan E. Tomkinson,et al. Repair of DNA double-strand breaks by mammalian alternative end-joining pathways , 2018, The Journal of Biological Chemistry.
[76] R. Mohan,et al. Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy , 2018, Journal of hepatocellular carcinoma.
[77] J. Hesser,et al. Using immunotherapy to boost the abscopal effect , 2018, Nature Reviews Cancer.
[78] Steven H. Lin,et al. A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. , 2018, Critical reviews in oncology/hematology.
[79] M. Durante,et al. Treatment planning with intensity modulated particle therapy for multiple targets in stage IV non-small cell lung cancer , 2018, Physics in medicine and biology.
[80] Samuel F. Bakhoum,et al. Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.
[81] A. Shibata,et al. 3D-structured illumination microscopy reveals clustered DNA double-strand break formation in widespread γH2AX foci after high LET heavy-ion particle radiation , 2017, Oncotarget.
[82] Tiara Bunga Mayang Permata,et al. DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells , 2017, Nature Communications.
[83] J. Parsons,et al. Complex DNA Damage Induced by High Linear Energy Transfer Alpha-Particles and Protons Triggers a Specific Cellular DNA Damage Response , 2017, International journal of radiation oncology, biology, physics.
[84] S. Formenti. Optimizing Dose Per Fraction: A New Chapter in the Story of the Abscopal Effect? , 2017, International journal of radiation oncology, biology, physics.
[85] M. Christmann,et al. Epigenetic regulation of DNA repair genes and implications for tumor therapy. , 2017, Mutation research.
[86] D. Gomez,et al. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. , 2017, International journal of radiation oncology, biology, physics.
[87] S. Demaria,et al. TREX1 dictates the immune fate of irradiated cancer cells , 2017, Oncoimmunology.
[88] Dennis E Discher,et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei , 2017, Nature.
[89] M. Durante,et al. Generating and grading the abscopal effect: proposal for comprehensive evaluation of combination immunoradiotherapy in mouse models , 2017 .
[90] C. N. Coleman,et al. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity , 2017, Nature Communications.
[91] Jan Theys,et al. Combining radiotherapy with immunotherapy: the past, the present and the future , 2017, The British journal of radiology.
[92] Marco Durante,et al. Charged-particle therapy in cancer: clinical uses and future perspectives , 2017, Nature Reviews Clinical Oncology.
[93] T. Nakano,et al. Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation , 2017, Journal of radiation research.
[94] I. Koturbash,et al. Effects of ionizing radiation on DNA methylation: from experimental biology to clinical applications , 2017, International journal of radiation biology.
[95] U. Kutay,et al. Mechanisms and functions of nuclear envelope remodelling , 2017, Nature Reviews Molecular Cell Biology.
[96] M. Durante,et al. Does Heavy Ion Therapy Work Through the Immune System? , 2016, International journal of radiation oncology, biology, physics.
[97] M. Prados,et al. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth. , 2016, Neuro-oncology.
[98] Zhijian J. Chen,et al. Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing , 2016, Nature Immunology.
[99] T. Illidge,et al. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy? , 2016, The British journal of radiology.
[100] T. Shimokawa,et al. The Future of Combining Carbon-Ion Radiotherapy with Immunotherapy: Evidence and Progress in Mouse Models. , 2016, International journal of particle therapy.
[101] A. Sartori,et al. Controlling DNA-End Resection: An Emerging Task for Ubiquitin and SUMO , 2016, Front. Genet..
[102] Marco Durante,et al. Nuclear physics in particle therapy: a review , 2016, Reports on progress in physics. Physical Society.
[103] J. Debus,et al. Next generation multi-scale biophysical characterization of high precision cancer particle radiotherapy using clinical proton, helium-, carbon- and oxygen ion beams , 2016, Oncotarget.
[104] J. Rodgers,et al. Short DNA Fragments Are a Hallmark of Heavy Charged-Particle Irradiation and May Underlie Their Greater Therapeutic Efficacy , 2016, Front. Oncol..
[105] M. Bernstein,et al. Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. , 2016, International journal of radiation oncology, biology, physics.
[106] Mechthild Krause,et al. Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.
[107] A. Shibata,et al. Visualization of complex DNA double-strand breaks in a tumor treated with carbon ion radiotherapy , 2016, Scientific Reports.
[108] M. Durante,et al. Efficient Rejoining of DNA Double-Strand Breaks despite Increased Cell-Killing Effectiveness following Spread-Out Bragg Peak Carbon-Ion Irradiation , 2016, Front. Oncol..
[109] S. Kampfer,et al. Paving the Road for Modern Particle Therapy – What Can We Learn from the Experience Gained with Fast Neutron Therapy in Munich? , 2015, Front. Oncol..
[110] T. Nakano,et al. Combining carbon ion irradiation and non-homologous end-joining repair inhibitor NU7026 efficiently kills cancer cells , 2015, Radiation oncology.
[111] T. Nakano,et al. Combining carbon ion irradiation and non-homologous end-joining repair inhibitor NU7026 efficiently kills cancer cells , 2015, Radiation Oncology.
[112] G. Iliakis,et al. Alternative end-joining repair pathways are the ultimate backup for abrogated classical non-homologous end-joining and homologous recombination repair: Implications for the formation of chromosome translocations. , 2015, Mutation research. Genetic toxicology and environmental mutagenesis.
[113] Matylda Sczaniecka-Clift,et al. Systematic E2 screening reveals a UBE2D–RNF138–CtIP axis promoting DNA repair , 2015, Nature Cell Biology.
[114] Matthias Guckenberger,et al. Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[115] S. Penfold,et al. Development of a radiation track structure clustering algorithm for the prediction of DNA DSB yields and radiation induced cell death in Eukaryotic cells , 2015, Physics in medicine and biology.
[116] Martin L. Miller,et al. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.
[117] Yoshiyuki Suzuki,et al. Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation , 2015, Journal of radiation research.
[118] Takeji Sakae,et al. The Major DNA Repair Pathway after Both Proton and Carbon-Ion Radiation is NHEJ, but the HR Pathway is More Relevant in Carbon Ions , 2015, Radiation research.
[119] R. Pötter,et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. , 2015, The Lancet. Oncology.
[120] M. Durante,et al. DNA end resection is needed for the repair of complex lesions in G1-phase human cells , 2014, Cell cycle.
[121] T. Nakano,et al. Nonhomologous End-Joining Repair Plays a More Important Role than Homologous Recombination Repair in Defining Radiosensitivity after Exposure to High-LET Radiation , 2014, Radiation research.
[122] S. Demaria,et al. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death , 2014, Oncoimmunology.
[123] G. Kornek,et al. Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments , 2013, Expert review of clinical pharmacology.
[124] P. Jeggo,et al. The complexity of DNA double strand breaks is a critical factor enhancing end-resection. , 2013, DNA repair.
[125] M Durante,et al. Including oxygen enhancement ratio in ion beam treatment planning: model implementation and experimental verification , 2013, Physics in medicine and biology.
[126] S. Demaria,et al. Radiation as an immunological adjuvant: current evidence on dose and fractionation , 2012, Front. Oncol..
[127] K. Iwamoto,et al. Maximizing tumor immunity with fractionated radiation. , 2012, International journal of radiation oncology, biology, physics.
[128] P. Jeggo,et al. The role of homologous recombination in radiation-induced double-strand break repair. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[129] David J. Chen,et al. Unrepaired clustered DNA lesions induce chromosome breakage in human cells , 2011, Proceedings of the National Academy of Sciences.
[130] M. Durante,et al. Protein acetylation within the cellular response to radiation , 2011, Journal of cellular physiology.
[131] J. Baulch,et al. The Effect of Radiation Quality on Genomic DNA Methylation Profiles in Irradiated Human Cell Lines , 2011, Radiation research.
[132] J. Baulch,et al. Radiation-induced epigenetic alterations after low and high LET irradiations. , 2011, Mutation research.
[133] Jayanta Chaudhuri,et al. CtIP promotes microhomology-mediated alternative end-joining during class switch recombination , 2010, Nature Structural &Molecular Biology.
[134] T. Nakano,et al. Combining carbon ion radiotherapy and local injection of α-galactosylceramide-pulsed dendritic cells inhibits lung metastases in an in vivo murine model. , 2010, International journal of radiation oncology, biology, physics.
[135] M. Durante,et al. Heavy-ion induced chromosomal aberrations: a review. , 2010, Mutation research.
[136] Y. Yonemitsu,et al. Carbon‐ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma , 2010, Cancer.
[137] S W Hell,et al. Biological dose estimation of UVA laser microirradiation utilizing charged particle-induced protein foci. , 2010, Mutagenesis.
[138] N. Kawashima,et al. Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody , 2009, Clinical Cancer Research.
[139] Irene L. Ibañez,et al. Induction and rejoining of DNA double strand breaks assessed by H2AX phosphorylation in melanoma cells irradiated with proton and lithium beams. , 2009, International journal of radiation oncology, biology, physics.
[140] S. Demaria,et al. Systemic effects of local radiotherapy. , 2009, The Lancet. Oncology.
[141] M. Beuve,et al. Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays. , 2009, International journal of radiation oncology, biology, physics.
[142] M. Durante,et al. Live cell microscopy analysis of radiation-induced DNA double-strand break motion , 2009, Proceedings of the National Academy of Sciences.
[143] Hans Blattmann,et al. Tumor therapy with heavy charged particles , 2008 .
[144] J. Wise,et al. Mutation research, genetic toxicology and environmental mutagenesis , 2005 .
[145] J. Kiefer. Mutagenic effects of heavy charged particles. , 2002, Journal of radiation research.
[146] M. Durante,et al. X-rays vs. carbon-ion tumor therapy: cytogenetic damage in lymphocytes. , 2000, International journal of radiation oncology, biology, physics.
[147] T. Phillips,et al. Neon ion radiotherapy: results of the phase I/II clinical trial. , 1991, International journal of radiation oncology, biology, physics.
[148] M. Durante,et al. Proton theraPy sPecial feature: review article harnessing radiation to improve immunotherapy: better with particles? , 2020 .
[149] P. Venkat,et al. Systematic review of case reports on the abscopal effect. , 2016, Current problems in cancer.
[150] A. Coray,et al. Deficiency in homologous recombination renders Mammalian cells more sensitive to proton versus photon irradiation. , 2014, International journal of radiation oncology, biology, physics.
[151] Y. Miki,et al. [PARP inhibitors for cancer therapy]. , 2011, Gan to kagaku ryoho. Cancer & chemotherapy.
[152] Yu Zhang,et al. An essential role for CtIP in chromosomal translocation formation through an alternative end-joining pathway , 2011, Nature Structural &Molecular Biology.
[153] T. Delaney. Proton therapy in the clinic. , 2011, Frontiers of radiation therapy and oncology.
[154] A. Takahashi,et al. High LET heavy ion radiation induces p53-independent apoptosis. , 2009, Journal of radiation research.
[155] George D Wilson,et al. Biologic basis for combining drugs with radiation. , 2006, Seminars in radiation oncology.
[156] D T Goodhead,et al. Track structure in radiation biology: theory and applications. , 1998, International journal of radiation biology.